35 results on '"Morita M"'
Search Results
2. The Activities of Coenzyme Q10 and Vitamin B6 for Immune Responses
- Author
-
Folkers, K., primary, Morita, M., additional, and Mcree, J., additional
- Published
- 1993
- Full Text
- View/download PDF
3. Survival of Cancer Patients on Therapy with Coenzyme Q10
- Author
-
Folkers, K., primary, Brown, R., additional, Judy, W.V., additional, and Morita, M., additional
- Published
- 1993
- Full Text
- View/download PDF
4. A New Method to Determine the Level of Coenzyme Q10 in One Drop of Human Blood for Biomedical Research
- Author
-
Morita, M., primary and Folkers, K., additional
- Published
- 1993
- Full Text
- View/download PDF
5. A New Method to Determine the Level of Coenzyme Q10in One Drop of Human Blood for Biomedical Research
- Author
-
Morita, M. and Folkers, K.
- Abstract
This method has been designed to determine the levels of CoQ10in human blood which utilizes only one drop of blood (0.05 ml). This method encourages and facilitates more frequent monitoring of blood levels of CoQ10, and of clinical importance, reveals the presence or absence of compliance. CoQ11was used as an internal standard. The mean recovery of CoQ10was 96%. The correlation coefficient between using 1.0 ml and 0.1 ml of blood and between using 1.0 and 0.05 ml was 0.997 in the two comparisons. Therefore, it can be accurate to monitor the level of CoQ10in a-"finger-prick"-drop of blood, and at least 24 such determinations can be conducted in a 2-day period.
- Published
- 1993
- Full Text
- View/download PDF
6. The establishment of a novel high-throughput screening system using RNA-guided genome editing to identify chemicals that suppress aldosterone synthase expression.
- Author
-
Ito R, Morita M, Nakano T, Sato I, Yokoyama A, and Sugawara A
- Subjects
- Adrenal Cortex drug effects, Adrenal Cortex metabolism, Aldosterone biosynthesis, Base Sequence, Calcium Signaling, Cell Line, Drug Evaluation, Preclinical methods, Gene Expression Regulation, Enzymologic drug effects, Genes, Reporter, Humans, Hyperaldosteronism drug therapy, Hyperaldosteronism genetics, Hyperaldosteronism metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Steroid 11-beta-Hydroxylase genetics, Tacrolimus pharmacology, RNA, Guide, CRISPR-Cas Systems, Cytochrome P-450 CYP11B2 antagonists & inhibitors, Cytochrome P-450 CYP11B2 genetics, Gene Editing methods, High-Throughput Screening Assays methods
- Abstract
Aldosterone is synthesized in the adrenal by the aldosterone synthase CYP11B2. Although the control of CYP11B2 expression is important to maintain the mineral homeostasis, its overexpression induced by the depolarization-induced calcium (Ca
2+ ) signaling activation has been reported to increase the synthesis of aldosterone in primary aldosteronism (PA). The drug against PA focused on the suppression of CYP11B2 expression has not yet been developed, since the molecular mechanism of CYP11B2 transcriptional regulation activated via Ca2+ signaling remains unclear. To address the issue, we attempted to reveal the mechanism of the transcriptional regulation of CYP11B2 using chemical screening. We generated a cell line by inserting Nanoluc gene as a reporter into CYP11B2 locus in H295R adrenocortical cells using the CRSPR/Cas9 system, and established the high-throughput screening system using the cell line. We then identified 9 compounds that inhibited the CYP11B2 expression induced by potassium-mediated depolarization from the validated compound library (3399 compounds). Particularly, tacrolimus, an inhibitor of phosphatase calcineurin, strongly suppressed the CYP11B2 expression even at 10 nM. These results suggest that the system is effective in identifying drugs that suppress the depolarization-induced CYP11B2 expression. Our screening system may therefore be a useful tool for the development of novel medicines against PA., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
7. Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagy.
- Author
-
Kikuchi N, Soga T, Nomura M, Sato T, Sakamoto Y, Tanaka R, Abe J, Morita M, Shima H, Okada Y, and Tanuma N
- Subjects
- Animals, Autophagy, Autophagy-Related Protein 7 genetics, Autophagy-Related Protein 7 metabolism, Cell Line, Tumor, Female, Gene Deletion, Ischemia etiology, Ischemia genetics, Ischemia pathology, Lung Neoplasms genetics, Lung Neoplasms pathology, Mice, Citric Acid Cycle, Ischemia metabolism, Lung Neoplasms metabolism, Lung Neoplasms surgery, Metabolome
- Abstract
Recent advances in cancer biology reveal the importance of metabolic changes in cancer; however, less is known about how metabolic pathways in tumors are regulated in vivo. Here, we report analysis of the lung cancer metabolism based on different surgical procedures, namely lobectomy and partial resection. In lobectomy, but not in partial resection, pulmonary arteries and veins are ligated prior to removal of tissues, rendering tissues ischemic. We show that tumors indeed undergo ischemia upon lobectomy and that the tumor metabolome differs markedly from that of tumors removed by partial resection. Comparison of the responses to ischemia in tumor and normal lung tissues revealed that lung cancer tissue exhibits greater TCA cycle and autophagic activity than do normal lung tissues in vivo in patients. Finally, we report that deleting ATG7, which encodes a protein essential for autophagy, antagonizes growth of tumors derived from lung cancer cell lines, suggesting that autophagy confers metabolic advantages to lung cancer. Our findings shed light on divergent metabolic responses to ischemia seen in tumors and normal tissues., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
8. Transforming growth factor β1-induced collagen production in myofibroblasts is mediated by reactive oxygen species derived from NADPH oxidase 4.
- Author
-
Hotta Y, Uchiyama K, Takagi T, Kashiwagi S, Nakano T, Mukai R, Toyokawa Y, Yasuda T, Ueda T, Suyama Y, Murakami T, Tanaka M, Majima A, Doi T, Hirai Y, Mizushima K, Morita M, Higashimura Y, Inoue K, Fukui A, Okayama T, Katada K, Kamada K, Handa O, Ishikawa T, Naito Y, and Itoh Y
- Subjects
- Animals, Cell Line, Mice, Myofibroblasts drug effects, NADPH Oxidase 4 genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Collagen biosynthesis, Myofibroblasts metabolism, NADPH Oxidase 4 metabolism, Reactive Oxygen Species metabolism, Transforming Growth Factor beta1 pharmacology
- Abstract
Intestinal fibrosis with stricture formation is a severe complication of Crohn's disease (CD). Though new therapeutic targets to enable the prevention or treatment of intestinal fibrosis are needed, markers of this condition and the basic mechanisms responsible have not been established. NADPH oxidase (NOX) 4 has already been reported to play a key role in models of fibrogenesis, including that of the lung. However, its importance in intestinal fibrogenesis remains unclear. In this study, we examined the role of NOX4 in collagen production by intestinal myofibroblasts stimulated with transforming growth factor (TGF)-β1. Using LmcMF cells, an intestinal subepithelial myofibroblast (ISEMF) line, we first examined the induction of collagen production by TGF-β1. Subsequently, we investigated the role of NOX4 in TGF-β1-induced collagen I production in these cells using SB525334 (an SMAD2/3 inhibitor), diphenyleneiodonium (an NOX inhibitor), and Nox4 small interfering RNA (siRNA). Production of collagen was assessed with Sirius red staining, and Nox4 expression was measured by quantitative real-time PCR. Reactive oxygen species (ROS) production was determined using DCFDA and fluorescent microscopy. We observed that TGF-β1 induced collagen production via NOX4 activation and ROS generation in LmcMF cells. Nox4 siRNA and inhibitors of TGF-β1 receptor and NOX significantly reduced TGF-β1-induced ROS and collagen production. Thus, in the present study, we revealed that collagen production in ISEMFs is induced via an NOX4-dependent pathway. This work supports a function for NOX4 in intestinal fibrogenesis and identifies it as a potential therapeutic target in recalcitrant fibrotic disorders of CD patients., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
9. Characterization of human ATP-binding cassette protein subfamily D reconstituted into proteoliposomes.
- Author
-
Okamoto T, Kawaguchi K, Watanabe S, Agustina R, Ikejima T, Ikeda K, Nakano M, Morita M, and Imanaka T
- Subjects
- Binding Sites, Enzyme Activation, Enzyme Stability, Kinetics, Protein Binding, ATP Binding Cassette Transporter, Subfamily D chemistry, Liposomes chemistry, Proteolipids chemistry
- Abstract
In mammals, four ATP-binding cassette (ABC) proteins belonging to subfamily D have been identified. ABCD1‒3 are located on peroxisomal membrane and play an important role in the transportation of various fatty acid-CoA derivatives, including very long chain fatty acid-CoA, into peroxisomes. ABCD4 is located on lysosomal membrane and is suggested to be involved in the transport of vitamin B
12 from lysosomes to the cytosol. However, the precise transport mechanism by which these ABC transporters facilitate the import or export of substrate has yet to be well elucidated. In this study, the overexpression of human ABCD1‒4 in the methylotrophic yeast Pichia pastoris and a purification procedure were developed. The detergent-solubilized proteins were reconstituted into liposomes. ABCD1‒4 displayed stable ATPase activity, which was inhibited by AlF3 . Furthermore, ABCD1‒4 were found to possess an equal levels of acyl-CoA thioesterase activity. Proteoliposomes is expected to be an aid in the further biochemical characterization of ABCD transporters., (Copyright © 2018 Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
10. Selective estrogen receptor modulators and the vitamin D analogue eldecalcitol block bone loss in male osteoporosis.
- Author
-
Sato Y, Tando T, Morita M, Miyamoto K, Kobayashi T, Watanabe R, Oike T, Matsumoto M, Nakamura M, and Miyamoto T
- Subjects
- Animals, Bone Density, Bone Density Conservation Agents pharmacology, Bone Diseases, Metabolic chemically induced, Bone Diseases, Metabolic prevention & control, Bone Resorption chemically induced, Bone and Bones drug effects, Indoles pharmacology, Male, Mice, Mice, Inbred C57BL, Orchiectomy, Raloxifene Hydrochloride pharmacology, Tamoxifen pharmacology, Testosterone deficiency, Vitamin D pharmacology, Bone Resorption prevention & control, Osteoporosis drug therapy, Selective Estrogen Receptor Modulators pharmacology, Vitamin D analogs & derivatives
- Abstract
Rapid increases in the number of elderly people have dramatically increased the number of female and male osteoporosis patients. Osteoporosis often causes bone fragility fractures, and males exhibit particularly poor prognosis after these fractures, indicating that control of osteoporosis is crucial to maintain quality of men's lives. However, osteoporosis therapies available for men have lagged behind advances available for women. Here, we show that three selective estrogen receptor modulators (SERMs), namely, raloxifene, bazedoxifene, and tamoxifen, plus the vitamin D analogue ED71, also called eldecalcitol, completely block orchiectomy-induced, testosterone-depleted bone loss in male mice in vivo. Patients treated with hormone deprivation therapy for prostate cancer also exhibit male osteoporosis, and bone management is critical for these patients. Given that androgen replacement therapy is not an option for these patients, our results represent a novel approach potentially useful to control male osteoporosis., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
11. Ibandronate concomitantly blocks immobilization-induced bone and muscle atrophy.
- Author
-
Watanabe R, Fujita N, Takeda S, Sato Y, Kobayashi T, Morita M, Oike T, Miyamoto K, Matsumoto Y, Matsumoto M, Nakamura M, and Miyamoto T
- Subjects
- Animals, Bone Density Conservation Agents pharmacology, Bone Resorption etiology, Cell Line, Dose-Response Relationship, Drug, Female, Ibandronic Acid, Mice, Mice, Inbred C57BL, Muscular Atrophy etiology, Organ Size drug effects, Proteasome Endopeptidase Complex metabolism, Treatment Outcome, Ubiquitination drug effects, Bone Resorption physiopathology, Bone Resorption prevention & control, Diphosphonates pharmacology, Immobilization adverse effects, Muscular Atrophy physiopathology, Muscular Atrophy prevention & control
- Abstract
Both bone and muscle volume is concomitantly reduced under immobilization conditions; however, no single drug is currently available to block these outcomes simultaneously. Bisphosphonates are utilized clinically to inhibit osteoclast-dependent bone resorption, but their effects on muscle are largely unknown. Here we show that skeletal muscle is a direct target of the bisphosphonate ibandronate (IBN) and that reduced muscle volume and induction of Atrogin-1 and MuRF1, both atrogenes, are significantly inhibited by IBN administration in vivo using a mouse model of muscle atrophy. IBN treatment also significantly blocked immobilization-induced bone loss in vivo. We also report that expression of Atrogin-1 and MuRF1 and accumulation of Smad2/3 proteins, which are upstream of atrogines, occurred following serum starvation of myogenic C2C12 cells in vitro, effects significantly inhibited by IBN treatment. Interestingly, IBN effects on C2C12 cells were abrogated by MG132, an ubiquitin/proteasome inhibitor, suggesting that IBN functions via the ubiquitin-proteasome system. Our findings lend new insight into the role of IBN in preventing muscle atrophy., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
12. Protein polysulfidation-dependent persulfide dioxygenase activity of ethylmalonic encephalopathy protein 1.
- Author
-
Jung M, Kasamatsu S, Matsunaga T, Akashi S, Ono K, Nishimura A, Morita M, Abdul Hamid H, Fujii S, Kitamura H, Sawa T, Ida T, Motohashi H, and Akaike T
- Subjects
- A549 Cells, Cysteine chemistry, Dioxygenases genetics, Dioxygenases metabolism, Disulfides metabolism, Glutathione analogs & derivatives, Glutathione metabolism, Humans, Mitochondrial Proteins genetics, Nucleocytoplasmic Transport Proteins genetics, Proteins chemistry, Substrate Specificity, Sulfides metabolism, Mitochondrial Proteins metabolism, Nucleocytoplasmic Transport Proteins metabolism, Proteins metabolism
- Abstract
Reactive persulfide species such as glutathione persulfide (GSSH) are highly abundant biomolecules. Persulfide dioxygenase (also called ethylmalonic encephalopathy protein 1, ETHE1) reportedly metabolizes GSSH to GSH with simultaneous oxygen consumption. How ETHE1 activity is regulated is still unclear, however. In this study, we describe the possible role of protein polysulfidation in the catalytic activity of ETHE1. We first found that ETHE1 catalyzed the persulfide dioxygenase reaction mostly for glutathione polysulfides, GS-(S)
n -H, as well as for GSSH, but not for other endogenous persulfides such as cysteine and homocysteine persulfides/polysulfides. We then developed a novel method to detect protein polysulfidation and named it the polyethylene glycol-conjugated maleimide-labeling gel shift assay (PMSA). PMSA analysis indicated that most cysteine residues in ETHE1 were polysulfidated. Site-directed mutagenesis of cysteine residues in ETHE1 combined with liquid chromatography tandem mass spectrometry for polysulfidation determination surprisingly indicated that the Cys247 residue was important for polysulfidation of other Cys residues and that the C247S mutant possessed no persulfide dioxygenase activity. These results suggested that ETHE1 is a major enzyme regulating endogenous GSSH/GS-(S)n -H and that its activity is controlled by polysulfidation of the Cys247 residue., (Copyright © 2016 Elsevier Inc. All rights reserved.)- Published
- 2016
- Full Text
- View/download PDF
13. Castration induced browning in subcutaneous white adipose tissue in male mice.
- Author
-
Hashimoto O, Noda T, Morita A, Morita M, Ohtsuki H, Sugiyama M, and Funaba M
- Subjects
- Adipocytes metabolism, Animals, Body Temperature, Body Weight, Diet, High-Fat, Gene Expression, Immunohistochemistry, Male, Mice, Inbred C57BL, Reverse Transcriptase Polymerase Chain Reaction, Thermogenesis, Uncoupling Protein 1 genetics, Uncoupling Protein 1 metabolism, Adipose Tissue, Brown metabolism, Adipose Tissue, White metabolism, Orchiectomy, Subcutaneous Fat metabolism
- Abstract
We demonstrated that castration enhanced the expression of uncoupling protein 1 (Ucp1), a thermogenic protein, in brown adipose tissue (BAT) and subcutaneous (sc) white adipose tissue (WAT) in male mice. Castration of male mice increased body temperature and reduced body weight gain compared with those of sham-operated mice. BAT Ucp1 mRNA expression in castrated male mice was significantly higher than that in sham-operated mice. Histologically, cells with multilocular fat droplets were observed in the castrated inguinal scWAT. Immunohistochemical staining revealed that these cells positively reacted with the anti-Ucp1 antibody. The Ucp1-positive area near the inguinal lymph node in the castrated WAT was extensive compared with that of the sham-operated WAT. Castration-induced Ucp1 up-regulation in scWAT was suppressed by high-fat diet feeding. These findings suggest that thermogenesis by BAT activation and scWAT browning contribute to castration-induced inhibition of body weight gain. However, considering that the effect of castration was blunted by high-fat diet consumption, thermogenesis stimulation in response to castration is inhibited by chronic over-nutrition., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
14. Autophagy is an important metabolic pathway to determine leukemia cell survival following suppression of the glycolytic pathway.
- Author
-
Kawaguchi M, Aoki S, Hirao T, Morita M, and Ito K
- Subjects
- Energy Metabolism, Humans, Jurkat Cells, Mitochondria metabolism, Autophagy, Cell Survival, Glucose metabolism, Glycolysis, Leukemia metabolism, Leukemia pathology
- Abstract
Most cancer cells predominantly produce energy by glycolysis, even in the presence of adequate oxygen. Therefore, inhibition of glycolysis is a promising cancer treatment target. Recently, it has been recognized that to conduct thorough treatment of cancer, comprehensive understanding of cancer metabolism is essential, not only focusing on glycolysis. Here, we investigated the supporting mechanism of autophagy, which is a catabolic process that recycles intracellular components, for energy supply in the glycolysis-inhibited condition. Autophagy is thought to be highly activated in cancers and to promote their growth or progression by adapting to the harsh surrounding microenvironment. We found that cancer cells positively promoted autophagy to overcome the energy shortage from glycolysis by maintaining mitochondrial activity for ATP production essential for survival. Conclusively, autophagy plays a role in determining whether cancer cells live or die, and autophagic ability in cancer cells is a promising target for therapy., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
15. Hif1α is required for osteoclast activation and bone loss in male osteoporosis.
- Author
-
Tando T, Sato Y, Miyamoto K, Morita M, Kobayashi T, Funayama A, Kanaji A, Hao W, Watanabe R, Oike T, Nakamura M, Matsumoto M, Toyama Y, and Miyamoto T
- Subjects
- Animals, Male, Mice, Mice, Inbred C57BL, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Osteoclasts metabolism, Osteoclasts pathology, Osteoporosis metabolism, Osteoporosis pathology, Testosterone metabolism
- Abstract
The number of osteoporosis patients is increasing not only in women but in men. Male osteoporosis occurs due to aging or androgen depletion therapies, leading to fractures. However, molecular mechanisms underlying male osteoporosis remain unidentified. Here, we show that hypoxia inducible factor 1 alpha (Hif1α) is required for development of testosterone deficiency-induced male osteoporosis. We found that in mice Hif1α protein accumulates in osteoclasts following orchidectomy (ORX) in vivo. In vitro, Hif1α protein accumulated in osteoclasts cultured in hypoxic conditions, but Hif1α protein rather than mRNA levels were suppressed by testosterone treatment, even in hypoxia. Administration of a Hif1α inhibitor to ORX mice abrogated testosterone deficiency-induced osteoclast activation and bone loss but did not alter osteoclast activities or bone phenotypes in sham-operated, testosterone-sufficient animals. We conclude that Hif1α protein accumulation due to testosterone-deficiency promotes development of male osteoporosis. Thus Hif1α protein could be targeted to inhibit pathologically-activated osteoclasts under testosterone-deficient conditions to treat male osteoporosis patients., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
16. Bcl6 promotes osteoblastogenesis through Stat1 inhibition.
- Author
-
Fujie A, Funayama A, Miyauchi Y, Sato Y, Kobayashi T, Kanagawa H, Katsuyama E, Hao W, Tando T, Watanabe R, Morita M, Miyamoto K, Kanaji A, Morioka H, Matsumoto M, Toyama Y, and Miyamoto T
- Subjects
- 3T3 Cells, Animals, Binding Sites genetics, Bone Remodeling genetics, Bone Remodeling physiology, Cell Differentiation genetics, Cell Differentiation physiology, DNA genetics, DNA metabolism, DNA-Binding Proteins deficiency, DNA-Binding Proteins genetics, Female, Mice, Mice, Inbred C57BL, Mice, Knockout, Osteoblasts cytology, Osteoclasts cytology, Osteoclasts metabolism, Osteogenesis genetics, Promoter Regions, Genetic, Proto-Oncogene Proteins c-bcl-6, RNA, Messenger genetics, RNA, Messenger metabolism, STAT1 Transcription Factor deficiency, STAT1 Transcription Factor genetics, DNA-Binding Proteins metabolism, Osteoblasts metabolism, Osteogenesis physiology, STAT1 Transcription Factor antagonists & inhibitors
- Abstract
Bone mass is tightly controlled by a balance between osteoclast and osteoblast activities. Although these cell types mature via different pathways, some factors reportedly regulate differentiation of both. Here, in a search for factors governing osteoblastogenesis but also expressed in osteoclasts to control both cell types by one molecule, we identified B cell lymphoma 6 (Bcl6) as one of those factors and show that it promotes osteoblast differentiation. Bcl6 was previously shown to negatively regulate osteoclastogenesis. We report that lack of Bcl6 results in significant inhibition of osteoblastogensis in vivo and in vitro and in defects in secondary ossification center formation in vivo. Signal transducer and activator of transcription 1 (Stat1) reportedly attenuates osteoblast differentiation by inhibiting nuclear translocation of runt-related transcription factor 2 (Runx2), which is essential for osteoblast differentiation. We found that lack of Bcl6 resulted in significant elevation of Stat1 mRNA and protein expression in osteoblasts and showed that Stat1 is a direct target of Bcl6 using a chromatin immune-precipitation assay. Mice lacking both Bcl6 and Stat1 (DKO) exhibited significant rescue of bone mass and osteoblastic parameters as well as partial rescue of secondary ossification center formation compared with Bcl6-deficient mice in vivo. Altered osteoblastogenesis in Bcl6-deficient cells was also restored in DKO in vitro. Thus, Bcl6 plays crucial roles in regulating both osteoblast activation and osteoclast inhibition., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
17. Therapeutic potential of human adipose tissue-derived multi-lineage progenitor cells in liver fibrosis.
- Author
-
Okura H, Soeda M, Morita M, Fujita M, Naba K, Ito C, Ichinose A, and Matsuyama A
- Subjects
- Adult, Animals, Carbon Tetrachloride, Female, Humans, Liver Cirrhosis blood, Liver Cirrhosis pathology, Liver Cirrhosis physiopathology, Liver Function Tests, Matrix Metalloproteinases metabolism, Mesenchymal Stem Cells enzymology, Mice, Nude, Middle Aged, Recovery of Function, Young Adult, Adipose Tissue cytology, Cell Lineage, Liver Cirrhosis therapy, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells cytology
- Abstract
Introduction: Liver fibrosis is characterized by excessive accumulation of extracellular matrix. In a mouse model of liver fibrosis, systemic injection of bone marrow mesenchymal stem cells (BM-MSCs) was considered to rescue the diseased phenotype. The aim of this study was to assess the effectiveness of human adipose tissue-derived multi-lineage progenitor cells (hADMPCs) in improving liver fibrosis., Methods and Results: hADMPCs were isolated from subcutaneous adipose tissues of healthy volunteers and expanded. Six week-old male nude mice were treated with carbon tetra-chloride (CCl4) by intraperitoneal injection twice a week for 6 weeks, followed by a tail vein injection of hADMPCs or placebo control. After 6 more weeks of CCl4 injection (12 weeks in all), nude mice with hADMPCs transplants exhibited a significant reduction in liver fibrosis, as evidenced by Sirius Red staining, compared with nude mice treated with CCl4 for 12 weeks without hADMPCs transplants. Moreover, serum glutamic pyruvate transaminase and total bilirubin levels in hADMPCs-treated nude mice were lower levels than those in placebo controls. Production of fibrinolytic enzyme MMPs from hADMPCs were examined by ELISA and compared to that from BM-MSCs. MMP-2 levels in the culture media were not significantly different, whereas those of MMP-3 and -9 of hADMPCs were higher than those by BM-MSCs., Conclusion: These results showed the mode of action and proof of concept of systemic injection of hADMPCs, which is a promising therapeutic intervention for the treatment of patients with liver fibrosis., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
18. Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability.
- Author
-
Morita M, Hayashi T, Ochiai M, Maeda M, Yamaguchi T, Ina K, and Kuzuya M
- Subjects
- Administration, Oral, Animals, Atherosclerosis prevention & control, Biological Availability, Cyclic GMP blood, Drug Synergism, Humans, Male, Rabbits, Rats, Rats, Sprague-Dawley, Signal Transduction drug effects, Arginine administration & dosage, Arginine blood, Citrulline administration & dosage, Dietary Supplements, Nitric Oxide blood
- Abstract
Background: Chronic supplementation with L-citrulline plus L-arginine has been shown to exhibit anti-atherosclerotic effects. However, the short-term action of this combination on the nitric oxide (NO)-cGMP pathway remains to be elucidated. The objective of the present study was to investigate the acute effects of a combination of oral L-citrulline and L-arginine on plasma L-arginine and NO levels, as well as on blood circulation., Methods: Rats or New Zealand white rabbits were treated orally with L-citrulline, or L-arginine, or a combination of each at half dosage. Following supplementation, plasma levels of L-arginine, NOx, cGMP and changes in blood circulation were determined sequentially., Results: L-Citrulline plus L-arginine supplementation caused a more rapid increase in plasma L-arginine levels and marked enhancement of NO bioavailability, including plasma cGMP concentrations, than with dosage with the single amino acids. Blood flow in the central ear artery in rabbits was also significantly increased by L-citrulline plus L-arginine administration as compared with the control., Conclusion: Our data show for the first time that a combination of oral L-citrulline and L-arginine effectively and rapidly augments NO-dependent responses at the acute stage. This approach may have clinical utility for the regulation of cardiovascular function in humans., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
19. Role of NH2-terminal hydrophobic motif in the subcellular localization of ATP-binding cassette protein subfamily D: common features in eukaryotic organisms.
- Author
-
Lee A, Asahina K, Okamoto T, Kawaguchi K, Kostsin DG, Kashiwayama Y, Takanashi K, Yazaki K, Imanaka T, and Morita M
- Subjects
- ATP-Binding Cassette Transporters chemistry, Animals, Arabidopsis metabolism, CHO Cells, Caenorhabditis elegans metabolism, Cricetinae, Cricetulus, Eukaryotic Cells metabolism, Fluorescent Antibody Technique, Hydrophobic and Hydrophilic Interactions, ATP-Binding Cassette Transporters metabolism, Subcellular Fractions metabolism
- Abstract
In mammals, four ATP-binding cassette (ABC) proteins belonging to subfamily D have been identified. ABCD1-3 possesses the NH2-terminal hydrophobic region and are targeted to peroxisomes, while ABCD4 lacking the region is targeted to the endoplasmic reticulum (ER). Based on hydropathy plot analysis, we found that several eukaryotes have ABCD protein homologs lacking the NH2-terminal hydrophobic segment (H0 motif). To investigate whether the role of the NH2-terminal H0 motif in subcellular localization is conserved across species, we expressed ABCD proteins from several species (metazoan, plant and fungi) in fusion with GFP in CHO cells and examined their subcellular localization. ABCD proteins possessing the NH2-terminal H0 motif were localized to peroxisomes, while ABCD proteins lacking this region lost this capacity. In addition, the deletion of the NH2-terminal H0 motif of ABCD protein resulted in their localization to the ER. These results suggest that the role of the NH2-terminal H0 motif in organelle targeting is widely conserved in living organisms., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
20. Self/non-self recognition mechanisms in sexual reproduction: new insight into the self-incompatibility system shared by flowering plants and hermaphroditic animals.
- Author
-
Sawada H, Morita M, and Iwano M
- Subjects
- Animals, Ciona intestinalis genetics, Ciona intestinalis physiology, Female, Hermaphroditic Organisms genetics, Magnoliopsida genetics, Male, Models, Biological, Reproduction genetics, Reproduction physiology, Self-Incompatibility in Flowering Plants genetics, Urochordata genetics, Urochordata physiology, Hermaphroditic Organisms physiology, Magnoliopsida physiology, Self-Incompatibility in Flowering Plants physiology
- Abstract
Sexual reproduction is an essential process for generating a genetic variety in the next generation. However, most flowering plants and hermaphroditic animals potentially allow self-fertilization. Approximately 60% of angiosperms possess a self-incompatibility (SI) system to avoid inbreeding. The SI system functions at a process of interaction between pollen (or pollen tube) and the pistil. These SI-responsible factors (S-determinants) in pollen and the pistil are encoded by highly polymorphic multiallelic genes in the S-locus, which are tightly linked making a single haplotype. Different taxonomic families utilize different types of S-determinant proteins. In contrast to the plant system, the mechanisms of SI in simultaneously hermaphroditic animals are largely unknown. Among them, promising candidates for SI in ascidians (primitive chordates) were recently identified. The SI system in the ascidian Cionaintestinalis was found to be very similar to those in flowering plants: The products of sperm- and egg-side multiallelic SI genes, which are tight linked and highly polymorphic, appear to be responsible for the SI system as revealed by genetic analysis. These findings led us to speculate that the SI systems in plants and animals evolved in a manner of convergent evolution. Here, we review the current understanding of the molecular mechanisms of the SI system in flowering plants, particularly Brassicacea, and in ascidians from the viewpoint of common mechanisms shared by plants and animals., (Copyright © 2014. Published by Elsevier Inc.)
- Published
- 2014
- Full Text
- View/download PDF
21. Uric acid induces NADPH oxidase-independent neutrophil extracellular trap formation.
- Author
-
Arai Y, Nishinaka Y, Arai T, Morita M, Mizugishi K, Adachi S, Takaori-Kondo A, Watanabe T, and Yamashita K
- Subjects
- Adult, Extracellular Fluid drug effects, Female, Granulomatous Disease, Chronic pathology, Humans, Male, Neutrophil Activation drug effects, Neutrophils drug effects, Neutrophils pathology, Young Adult, Extracellular Fluid immunology, Granulomatous Disease, Chronic immunology, NADPH Oxidases immunology, Neutrophil Activation immunology, Neutrophils immunology, Reactive Oxygen Species immunology, Uric Acid pharmacology
- Abstract
Neutrophil extracellular traps (NETs) are composed of extracellular DNA fibers with antimicrobial peptides that capture and kill microbes. NETs play a critical role in innate host defense and in autoimmune and inflammatory diseases. While the mechanism of NET formation remains unclear, reactive oxygen species (ROS) produced via activation of NADPH oxidase (Nox) are known to be an important requirement. In this study, we investigated the effect of uric acid (UA) on NET formation. UA, a well-known ROS scavenger, was found to suppress Nox-dependent ROS release in a dose-dependent manner. Low concentrations of UA significantly inhibited Nox-dependent NET formation. However, high concentrations of UA unexpectedly induced, rather than inhibited, NET formation. NETs were directly induced by UA alone in a Nox-independent manner, as revealed by experiments using control neutrophils treated with ROS inhibitors or neutrophils of patients with chronic granulomatous disease who have a congenital defect in ROS production. Furthermore, we found that UA-induced NET formation was partially mediated by NF-κB activation. Our study is the first to demonstrate the novel function of UA in NET formation and may provide insight into the management of patients with hyperuricemia., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
22. Involvement of CNOT3 in mitotic progression through inhibition of MAD1 expression.
- Author
-
Takahashi A, Kikuguchi C, Morita M, Shimodaira T, Tokai-Nishizumi N, Yokoyama K, Ohsugi M, Suzuki T, and Yamamoto T
- Subjects
- Cell Cycle Proteins biosynthesis, Cell Cycle Proteins genetics, Gene Knockdown Techniques, HeLa Cells, Humans, Nuclear Proteins biosynthesis, Nuclear Proteins genetics, RNA Stability, RNA, Messenger biosynthesis, Spindle Apparatus metabolism, Transcription Factors genetics, Cell Cycle Proteins antagonists & inhibitors, Mitosis, Nuclear Proteins antagonists & inhibitors, Transcription Factors metabolism
- Abstract
The stability of mRNA influences the dynamics of gene expression. The CCR4-NOT complex, the major deadenylase in mammalian cells, shortens the mRNA poly(A) tail and contributes to the destabilization of mRNAs. The CCR4-NOT complex plays pivotal roles in various physiological functions, including cell proliferation, apoptosis, and metabolism. Here, we show that CNOT3, a subunit of the CCR4-NOT complex, is involved in the regulation of the spindle assembly checkpoint, suggesting that the CCR4-NOT complex also plays a part in the regulation of mitosis. CNOT3 depletion increases the population of mitotic-arrested cells and specifically increases the expression of MAD1 mRNA and its protein product that plays a part in the spindle assembly checkpoint. We showed that CNOT3 depletion stabilizes the MAD1 mRNA, and that MAD1 knockdown attenuates the CNOT3 depletion-induced increase of the mitotic index. Basing on these observations, we propose that CNOT3 is involved in the regulation of the spindle assembly checkpoint through its ability to regulate the stability of MAD1 mRNA., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
23. Fluorescent labeling of a carboxyl group of sialic acid for MALDI-MS analysis of sialyloligosaccharides and ganglioside.
- Author
-
Endo S, Morita M, Ueno M, Maeda T, and Terabayashi T
- Subjects
- Chromatography, High Pressure Liquid, Fluorescence, G(M3) Ganglioside analysis, Lactose analogs & derivatives, Lactose analysis, Aminopyridines chemistry, Ethylamines chemistry, Fluorescent Dyes chemistry, Gangliosides analysis, N-Acetylneuraminic Acid chemistry, Oligosaccharides analysis, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods
- Abstract
We developed a modified method enabling stable MALDI-MS analysis and fluorescent detection of sialyl-compounds. The modification involved the amidation of sialic acid (Neu5Ac) at the position of the carboxyl group using the fluorescent reagent, 2-(2-pyridilamino)ethylamine (PAEA). In this study the following sialyl-compounds were amidated, 3'-sialyllactose (3'-SL), 6'-sialyllactose (6'-SL), and ganglioside GM3. Yields of PAEA-3'-SL, PAEA-6'-SL, and PAEA-GM3 were 45%, 60%, and 30%, respectively. The PAEA-amidation enabled fluorescence detection of structural isomers using HPLC and TLC at sensitivity levels as low as pmol. In MALDI-TOF-MS and/or MS/MS analysis in positive ion mode, PAEA-amidation provided the following advantages: suppression of preferential cleavage of Neu5Ac; enhancement of molecular-related ion intensities; simplification of MS spectra; and finally, since PAEA-amidation did not cleave the linkage between sugar and aglycon of sialylglycoconjugate, MALDI-TOF-MS and MS/MS analyses revealed the complete structure of the molecule.
- Published
- 2009
- Full Text
- View/download PDF
24. Isolation of antigen/antibody complexes through organic solvent (ICOS) method.
- Author
-
Akahori Y, Kurosawa G, Sumitomo M, Morita M, Muramatsu C, Eguchi K, Tanaka M, Suzuki K, Sugiura M, Iba Y, Sugioka A, and Kurosawa Y
- Subjects
- Antibodies, Monoclonal chemistry, Antibodies, Monoclonal genetics, Antigen-Antibody Complex chemistry, Antigen-Antibody Complex genetics, Humans, Methods, Solvents chemistry, Antibodies, Monoclonal isolation & purification, Antigen-Antibody Complex isolation & purification, Membrane Proteins immunology, Peptide Library
- Abstract
We developed a method termed ICOS (isolation of antigen-antibody complexes through organic solvent) for comprehensive isolation of monoclonal antibodies (mAbs) bound to molecules on the cell surface. By mixing a large number of phage particles of an antibody (Ab) library with living cells, antigen (Ag)-Ab complexes were formed on the cell surface. The mixture was overlaid on organic solution in a tube and subjected to centrifugation. Phages bound to cells were recovered from the precipitate. The phage fraction isolated turned out to contain mAbs that bind to very heterogeneous epitopes and show strong binding activity to Ags. The ICOS method was applied to isolation of human mAbs that may be therapeutic against cancers. Sixty percent of clones isolated by the screening of a phage Ab library against cancer cells turned out to bind to various kinds of tumor-associated Ags. The precise protocol of ICOS method and the rationale of efficient screening were described.
- Published
- 2009
- Full Text
- View/download PDF
25. Inducibility of cytochrome P450 1A1 and chemical carcinogenesis by benzo[a]pyrene in AhR repressor-deficient mice.
- Author
-
Hosoya T, Harada N, Mimura J, Motohashi H, Takahashi S, Nakajima O, Morita M, Kawauchi S, Yamamoto M, and Fujii-Kuriyama Y
- Subjects
- Animals, Basic Helix-Loop-Helix Transcription Factors, Cell Transformation, Neoplastic chemically induced, Cell Transformation, Neoplastic metabolism, Cytochrome P-450 CYP1A1 analysis, Cytochrome P-450 CYP1A1 metabolism, Gene Expression, Gene Targeting, Inactivation, Metabolic genetics, Mice, Mice, Mutant Strains, Repressor Proteins analysis, Repressor Proteins genetics, Skin Neoplasms chemically induced, Skin Neoplasms pathology, Tissue Distribution, Benzo(a)pyrene toxicity, Cell Transformation, Neoplastic genetics, Cytochrome P-450 CYP1A1 genetics, Gene Expression Regulation, Neoplastic, Repressor Proteins physiology, Skin Neoplasms genetics
- Abstract
AhR repressor (AhRR) is an AhR-related bHLH-PAS transcription factor. It is known to repress AhR transcription activity in a competitive manner. To examine AhRR functions in mice, we produced AhRR-deficient mice by gene knockout. AhRR(-/-) mice were born in normal Mendelian proportions, grew well, and were fertile. AhR(-/-) mice exhibited higher levels of Cyp1a1 (Cytochrome P450 1A1) mRNA induction in the skin, stomach and spleen than wild-type mice, while expression of Cyp1a1 mRNA was not significantly altered in the liver, lung, heart or other tissues, suggesting that "super-induction" of Cyp1a1 mRNA expression in AhRR(-/-) mice occurs in a tissue specific manner. AhRR(-/-) mice displayed a delayed response to skin carcinogenesis caused by benzo[a]pyrene. Since CYP1A1 is involved in the metabolic activation and detoxification of chemical carcinogens, these results suggest that overexpression of CYP1A1 shifts the balance of the metabolic activities in the skin of AhRR(-/-) mice in favor of the detoxification of carcinogens.
- Published
- 2008
- Full Text
- View/download PDF
26. Mu-calpain is involved in the regulation of TNF-alpha-induced matrix metalloproteinase-3 release in a rheumatoid synovial cell line.
- Author
-
Morita M, Banno Y, Dohjima T, Nozawa S, Fushimi K, Fan DG, Ohno T, Miyazawa K, Liu N, and Shimizu K
- Subjects
- Calpain antagonists & inhibitors, Calpain biosynthesis, Cell Line, Cysteine Proteinase Inhibitors pharmacology, Humans, RNA Interference, Synovial Membrane cytology, Up-Regulation, Arthritis, Rheumatoid enzymology, Calpain physiology, Matrix Metalloproteinase 3 biosynthesis, Synovial Membrane enzymology, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Calpain is secreted by intra-articular synovial cells and degrades the main components of cartilage matrix proteins, proteoglycan, and collagen, causing cartilage destruction. Matrix metalloproteinase-3 (MMP-3) has also been detected in synovial fluid and serum, and is involved in the development and progression of rheumatoid arthritis by degradation of the extracellular matrix and cartilage destruction. To investigate the relationship between calpain and MMP-3 in rheumatic inflammation, we utilized the rheumatic synovial cell line, MH7A. Tumor necrosis factor (TNF-alpha) stimulation-induced increased expression of mu-calpain, m-calpain, and MMP-3 in these cells, as well as the release of calpain and MMP-3 into the culture medium. The calpain inhibitors, ALLN (calpain inhibitor I) and calpeptin, did not affect the intracellular expression of MMP-3, but reduced the secretion of MMP-3 in a concentration-dependent manner. Down-regulation of mu- but not m-calpain by small interfering RNAs abolished TNF-alpha-induced MMP-3 release from the synovial cells. These findings suggest that calpain, particularly mu-calpain, regulates MMP-3 release by rheumatic synovial cells, in addition to exerting its own degradative action on cartilage.
- Published
- 2006
- Full Text
- View/download PDF
27. The reaction of bisphenol A 3,4-quinone with DNA.
- Author
-
Edmonds JS, Nomachi M, Terasaki M, Morita M, Skelton BW, and White AH
- Subjects
- Benzhydryl Compounds, Mass Spectrometry, Nuclear Magnetic Resonance, Biomolecular, Oxidation-Reduction, Benzoquinones chemistry, DNA chemistry, Phenols chemistry
- Abstract
The 3,4-quinone of the estrogen-active compound bisphenol A (BPA), characterized by a single crystal X-ray structure determination, has been shown by (1)H NMR spectroscopy to react with herring testes DNA, and with deoxyguanosine (dG), in aqueous buffer at pH 7, to form a BPA 3,4-quinone-guanine-N7 adduct (BPAQ-N7-Gua). Presumably this adduct resulted from decomposition (by loss of deoxyribose) of an initially formed, but unstable, BPAQ-N7-dG adduct. Chemical synthesis if BPAQ-N7-Gua, in up to 60% yield, was achieved by the reaction of BPAQ and dG in aqueous acetic acid. Characterization of this product, by NMR spectroscopy and high resolution mass spectrometry, allowed the monitoring (by (1)H NMR spectroscopy) of the reaction of BPAQ with DNA and with dG. The relevance of this adduct formation to the potential mutagenicity and carcinogenicity of BPA will depend upon confirmation of the necessary metabolic oxidative transformation of BPA in vivo.
- Published
- 2004
- Full Text
- View/download PDF
28. Simultaneous imaging of phosphatidyl inositol metabolism and Ca2+ levels in PC12h cells.
- Author
-
Morita M, Yoshiki F, and Kudo Y
- Subjects
- Animals, Cell Nucleus metabolism, Cytosol metabolism, DNA metabolism, Green Fluorescent Proteins, Luminescent Proteins metabolism, Microscopy, Confocal methods, PC12 Cells, Protein Structure, Tertiary, Rats, Time Factors, Benzofurans pharmacology, Calcium metabolism, Imidazoles pharmacology, Phosphatidylinositols metabolism
- Abstract
To elucidate the spatial and temporal relationships between phosphatidyl inositol metabolism and changes in intracellular calcium levels, we developed a simultaneous imaging system using green fluorescent protein fused with the pleckstrin homology domain, and the fluorescent calcium indicator, FuraRed. The redistribution of the fusion protein, which represents the phosphatidyl inositol metabolism process, was quantified by calculating the coefficient of variance of the fluorescence over the entire cytosolic region, excluding the nucleus. This calculation increased the reproducibility, compared to the normalized fluorescence changes in arbitrarily selected cytosolic regions used in conventional analysis. The application of this method to analyzing the response of PC12h cells to a number of pharmacological stimuli showed that the extent of the phosphatidyl inositol metabolism was related to the calcium level, but not induced by calcium alone.
- Published
- 2003
- Full Text
- View/download PDF
29. Existence of catalase-less peroxisomes in Sf21 insect cells.
- Author
-
Kurisu M, Morita M, Kashiwayama Y, Yokota S, Hayashi H, Sakai Y, Ohkuma S, Nishimura M, and Imanaka T
- Subjects
- ATP Binding Cassette Transporter, Subfamily D, Member 1, ATP-Binding Cassette Transporters genetics, ATP-Binding Cassette Transporters metabolism, Animals, Base Sequence, Cell Line, DNA, Recombinant genetics, Fatty Acids metabolism, Green Fluorescent Proteins, Luminescent Proteins genetics, Luminescent Proteins metabolism, Microscopy, Immunoelectron, Oxidation-Reduction, Peroxisome-Targeting Signal 1 Receptor, Peroxisomes ultrastructure, Receptors, Cytoplasmic and Nuclear genetics, Receptors, Cytoplasmic and Nuclear metabolism, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Spodoptera, Subcellular Fractions metabolism, Catalase metabolism, Peroxisomes metabolism
- Abstract
Catalase activity, a peroxisomal marker enzyme, was not detectable in any of the subcellular fractions of Spodoptera frugiperda (Sf) 21 insect cells, although marker enzymes in other organelles were distributed in the fractions in a manner similar to that seen in mammalian cells. When a green fluorescent protein fused with peroxisome targeting signal 1 at the C-terminal (GFP-SKL) was expressed in Sf21 cells, punctate fluorescent dots were observed in the cytoplasm. The fraction where GFP-SKL was concentrated exhibited long-chain and very-long-chain fatty acid beta-oxidation activities in the presence of KCN and the density of this fraction was slightly higher than that of mitochondria. Immunoelectron microscopy studies with anti-SKL antibody demonstrated that Sf21 cells have immunoreactive peroxisome-like organelles which are structurally distinct from mitochondria, endoplasmic reticulum, and lysosomes. In contrast to peroxisomal matrix proteins, adrenoleukodystrophy protein, a peroxisomal membrane protein, was not located to peroxisomes. This suggests that the targeting signal for PMP in insect cells is distinct from that in mammalian cells. These results demonstrate that Sf21 insect cells have unique catalase-less peroxisomes capable of beta-oxidation of fatty acids.
- Published
- 2003
- Full Text
- View/download PDF
30. Nucleotide-induced conformational changes of PMP70, an ATP binding cassette transporter on rat liver peroxisomal membranes.
- Author
-
Kashiwayama Y, Morita M, Kamijo K, and Imanaka T
- Subjects
- ATP-Binding Cassette Transporters metabolism, Binding Sites, Dimerization, Liver cytology, Liver metabolism, Membrane Proteins metabolism, Peptide Fragments chemistry, Peptide Fragments metabolism, Peroxisomes metabolism, Protein Conformation, Trypsin metabolism, ATP-Binding Cassette Transporters chemistry, Adenosine Triphosphate metabolism, Membrane Proteins chemistry, Peroxisomes chemistry
- Abstract
Nucleotide-induced conformational changes of the 70-kDa peroxisomal membrane protein (PMP70) were investigated by means of limited-trypsin digestion. Rat liver peroxisomes preincubated with various nucleotides were subsequently digested by trypsin. The digestion products were subjected to immunoblot analysis with an anti-PMP70 antibody that recognizes the carboxyl-terminal 15 amino acids of the protein. PMP70 was initially cleaved in the boundary region between the transmembrane and nucleotide-binding domains and a carboxyl-terminal 30-kDa fragment resulted. The fragment in turn was progressively digested at the helical domain between the Walker A and B motifs. The fragment, however, could be stabilized with MgATP or MgADP. In contrast to MgATP, MgATP-gammaS protected whole PMP70 as well as the fragment. The 30-kDa fragment processed by trypsin was recovered in the post-peroxisomal fraction as a complex with a molecular mass of about 60 kDa irrespective of the presence of MgATP. These results suggest that PMP70 exists as a dimer on the peroxisomal membranes and the binding and hydrolysis of ATP induce conformational changes in PMP70 close to the boundary between the transmembrane and nucleotide binding domains and the helical domain between the Walker A and B motifs., ((C)2002 Elsevier Science (USA).)
- Published
- 2002
- Full Text
- View/download PDF
31. Genomic organization, chromosomal localization, and the complete 22 kb DNA sequence of the human GCMa/GCM1, a placenta-specific transcription factor gene.
- Author
-
Yamada K, Ogawa H, Tamiya G, Ikeno M, Morita M, Asakawa S, Shimizu N, and Okazaki T
- Subjects
- Animals, Base Sequence, Basic Helix-Loop-Helix Transcription Factors, Binding Sites, Chromosome Mapping, Chromosomes, Human, Pair 6, DNA, Complementary genetics, DNA-Binding Proteins metabolism, Exons, GATA2 Transcription Factor, GATA3 Transcription Factor, Gene Library, Host Cell Factor C1, Humans, In Situ Hybridization, Fluorescence, Introns, Mice, Models, Genetic, Molecular Sequence Data, Nuclear Proteins, Octamer Transcription Factor-1, Polymerase Chain Reaction, Sequence Homology, Nucleic Acid, Trans-Activators metabolism, Transcription Factors metabolism, Trophoblasts, Neuropeptides genetics, Placenta metabolism
- Abstract
The genomic sequence of the human GCMa/GCM1 gene, a mammalian homologue of Drosophila melanogaster GCM, was determined. Drosophila GCM is a neural transcription factor that regulates glial cell fate. The mammalian homolog however, is a placenta-specific transcription factor that is necessary for placental development. The 22 kb DNA sequence spanning the GCMa gene contains six exons and five introns, encoding a 2.8 kb cDNA. Overall genomic organization is similar for the human and mouse. Several potential binding sites for transcription factors like GATA, Oct-1, and bHLH proteins were found in the 5'-flanking region of the human gene. A DNA motif for GCM protein binding exists in the 5'-flanking region that is highly homologous with that of the mouse gene. The location of this gene was mapped to chromosome 6 using fluorescence in situ hybridization., (Copyright 2000 Academic Press.)
- Published
- 2000
- Full Text
- View/download PDF
32. Presence of dioxins in human follicular fluid: their possible stage-specific action on the development of preimplantation mouse embryos.
- Author
-
Tsutsumi O, Uechi H, Sone H, Yonemoto J, Takai Y, Momoeda M, Tohyama C, Hashimoto S, Morita M, and Taketani Y
- Subjects
- Animals, Dioxins metabolism, Female, Humans, Mice, Blastocyst drug effects, Dioxins pharmacology, Follicular Fluid metabolism
- Abstract
Examination of human follicular fluid revealed the presence of polychlorinated dibenzodioxins (PCDDs) and dibenzofurans (PCDFs) at concentrations of approximately 1 pg/ml (0.01 pg TEQ/ml). To study their possible action, two-cell mouse embryos were cultured in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at concentrations between 0.5 and 100 pM and evaluated at 24-h intervals for their development to the eight-cell and blastocyst stages. The percentage of eight-cell embryos exposed to TCDD at 1, 2, and 5 pM concentrations was significantly lower than that of controls. However, blastocyst formation of the surviving eight-cell embryos was accelerated, with the number of cells in the blastocysts increased in a dose-dependent manner. Findings suggest that PCDDs and PCDFs may be present in human reproductive fluid and may exert some stage-specific effects on early embryonic development.
- Published
- 1998
- Full Text
- View/download PDF
33. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer.
- Author
-
Folkers K, Osterborg A, Nylander M, Morita M, and Mellstedt H
- Subjects
- Animals, Breast Neoplasms blood, Coenzymes, Female, Humans, Male, Multiple Myeloma blood, Neoplasms, Experimental blood, Reference Values, Ubiquinone blood, Ubiquinone metabolism, Neoplasms blood, Ubiquinone analogs & derivatives
- Abstract
New data on blood levels of vitamin Q10 in 116 cancer patients reveal an incidence of 23.1% of patients (N=17) with breast cancer whose blood levels were below 0.5 microg/ml. The incidence of breast cancer cases with levels below 0.6 microg/ml was 38.5%. The incidence is higher (p<0.05) than that for a group of ordinary people. Patients (N=15) with myeloma showed a mean blood level of 0.67 +/- 0.17 microg/ml. The incidence of a vitamin Q10 blood level below 0.7 microg/ml for these 15 cases of myeloma was 53.3%, which is higher (p<0.05) than the 24.5% found for a group of ordinary people.
- Published
- 1997
- Full Text
- View/download PDF
34. cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization.
- Author
-
Ema M, Suzuki M, Morita M, Hirose K, Sogawa K, Matsuda Y, Gotoh O, Saijoh Y, Fujii H, Hamada H, and Fujii-Kuriyama Y
- Subjects
- Age Factors, Animals, Aryl Hydrocarbon Receptor Nuclear Translocator, Base Sequence, Basic Helix-Loop-Helix Transcription Factors, Chromosome Mapping, Cloning, Molecular, DNA Primers chemistry, Drosophila Proteins, Drosophila melanogaster genetics, Gene Expression Regulation, Developmental, Helix-Loop-Helix Motifs, In Situ Hybridization, Mice, Molecular Sequence Data, Protein Binding, RNA, Messenger genetics, Recombinant Proteins, Sequence Alignment, Sequence Homology, Amino Acid, Tissue Distribution, Transcription Factors metabolism, DNA, Complementary genetics, DNA-Binding Proteins genetics, Nuclear Proteins genetics, Receptors, Aryl Hydrocarbon
- Abstract
A combination of the RT-PCR method and subsequent screening of the cDNA library of mouse skeletal muscle with the cDNA isolated by RT-PCR used as a probe led to isolation of cDNAs encoding a polypeptide (mSim) with bHLH and PAS domains which show high similarity to the corresponding regions of Drosophila Sim, a master regulator in neurogenesis. Experiments using a GST-fusion protein demonstrated that mSim heterodimerizes with Arnt (Ah receptor nuclear translocator), even more efficiently than AhR (Ah receptor) does with Arnt. RNA blot analysis using RNAs from various tissues of mice indicated that mSim transcript is expressed in several limited tissues such as muscle, kidney and lung of adult animals. Distribution of mSim mRNA was always accompanied with that of Arnt. All the results suggest a regulatory role of mSim in partnership with Arnt. Chromosomal location of the mSim gene was determined by fluorescent in situ hybridization to be localized on the C3.3-C4 band of mouse chromosome 16 which is syntenic with the human chromosome 21q22 carrying the Down syndrome critical region, where a gene highly homologous to the Drosophila sim was localized. Whole mount in situ hybridization using a unique part of mSim cDNA sequence showed that mSim mRNA was expressed in the ventral diencephalon, branchial arches and limbs. These findings will provide an approach to the cause of the Down syndrome as well as the elucidation of the functional roles of mSim in animal development.
- Published
- 1996
- Full Text
- View/download PDF
35. Tumor necrosis factor alpha and interleukin-1 beta but not interferon gamma induce vascular cell adhesion molecule-1 expression on primary cultured murine hepatocytes.
- Author
-
Watanabe Y, Morita M, Ikematsu N, and Akaike T
- Subjects
- Animals, Base Sequence, Cell Adhesion Molecules genetics, Cells, Cultured, DNA Primers, Liver cytology, Mice, Molecular Sequence Data, Polymerase Chain Reaction, RNA, Messenger genetics, RNA, Messenger metabolism, Vascular Cell Adhesion Molecule-1, Cell Adhesion Molecules biosynthesis, Interferon-gamma pharmacology, Interleukin-1 pharmacology, Liver metabolism, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Inflammatory cytokines such as tumor necrosis factor alpha (TNF alpha), interferon gamma (IFN gamma) and interleukin-1 beta (IL-1 beta) play important roles in the mechanisms of hepatitis. The effects of these cytokines on the expression of vascular cell adhesion molecule-1 (VCAM-1) in hepatocytes were examined. TNF alpha and IL-1 beta but not IFN gamma or IL-6 induced VCAM-1 expression on primary cultured murine hepatocytes in a dose- and a time-dependent fashion. TNF alpha is significantly more effective than IL-1 beta on the induction of VCAM-1 expression. The results of RT-PCR demonstrate that these cytokines regulate VCAM-1 expression at mRNA level. These results suggest that TNF alpha and IL-1 beta participate in the pathogenesis of hepatitis via induction of VCAM-1 molecules on hepatocytes.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.